Unusual 11 Mid-Day Movers 7/15: TRGT, FOE, BEXP, GCI Higher; PAR, OXGN, UCBH, SSG Lower Jul 15, 2009 12:29PM

Targacept, Inc. (NASDAQ: TRGT) 133% HIGHER; announced positive top-line results from a double blind, placebo controlled, flexible dose Phase 2b clinical trial of TC-5214 as an augmentation (add-on) treatment for major depressive disorder, or MDD, in subjects who did not respond adequately to first-line treatment with citalopram alone. Click here for the full report.

Ferro Corp. (NYSE: FOE) 27.6% HIGHER; maybe trading higher on strong Q2 guidance from Lubrizol (NYSE: LZ). Also might be seeing upside following a report issued by Deutsche Bank after the close yesterday previewing production results for the Chemical sector this year. The stock could also be getting a boost from an announced production and sales increase at ...


Unusual 11 Mid-Day Movers 5/18: KONA, IDMI, GRO, REDF Higher; SPIR, EDZ, COIN, FAZ Lower May 18, 2009 12:53PM

Kona Grill Inc. (Nasdaq: KONA) 69.1% HIGHER; In an amended 13D filing on Kona, 9.8% holder Mill Road Capital disclosed a non-binding offer to acquire all of the Company’s shares for cash in a transaction valuing Kona's total enterprise value at $27.9 million or $4.60 per share.

IDM Pharma, Inc. (Nasdaq: IDMI) 53.5% HIGHER; Takeda Pharmaceutical Company Limited agreed to acquire IDM Pharma for US$2.64 per share in cash. Shares of IDMI closed at $1.70 per share on Friday, representing a deal premium of 55%. Click here for the full report.

Morning Movers 5/18: KONA, AHR, IDMI, LGTY, IBN, HEB Higher; SPIR, COIN, BIDZ, AYE Lower May 18, 2009 10:07AM

Kona Grill Inc. (Nasdaq: KONA) 90% HIGHER; In an amended 13D filing on Kona, 9.8% holder Mill Road Capital disclosed a non-binding offer to acquire all of the Company’s shares for cash in a transaction valuing Kona's total enterprise value at $27.9 million or $4.60 per share.

Anthracite Capital, Inc. (NYSE: AHR) 53.6% HIGHER; today announced that it has entered into a series of amendments to its secured credit facilities with Bank of America, Deutsche Bank, and Morgan Stanley. The facilities have been amended to provide similar terms which, among other things, extend the maturities of all facilities to September 30, 2010 and eliminate all mark to market provisions. In addition to eliminating outstanding margin calls and the right to make future margin calls, existing scheduled amortization payments were replaced with cash management requirements. Click here for the full report.

IDM Pharma, Inc ...